Funding for this research was provided by:
Ontario Institute for Cancer Research (Adaptive Oncology)
Text and Data Mining valid from 2019-08-09
Received: 25 March 2019
Accepted: 26 July 2019
First Online: 9 August 2019
Ethics approval and consent to participate
: This study had institutional review board approval. All patients underwent informed consent for participation in the original study. The need for additional consent for this study was waived, as only existing de-identified data were used in this analysis. The study was compliant with the Health Insurance Portability and Accountability Act. The committee’s reference number is IRB-HSR #15885.
: Not applicable.
: JAH has the following conflict: shareholder and research agreement with Volpara Analytics, LLC, Wellington, NZ. MJY has the following conflict: shareholder of Volpara Analytics, LLC, Wellington, NZ. The other authors declare that they have no competing interests.